{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:48:44Z","timestamp":1761630524131},"reference-count":23,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2009,7,30]],"date-time":"2009-07-30T00:00:00Z","timestamp":1248912000000},"content-version":"vor","delay-in-days":6846,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetic Medicine"],"published-print":{"date-parts":[[1990,11]]},"abstract":"<jats:p>To investigate whether persistent microalbuminuria is related to altered levels of both lipids and apolipoproteins in Type 2 diabetes mellitus serum total\u2010cholesterol, triglycerides, HDL\u2010cholesterol, LDL\u2010cholesterol, apolipoprotein A\u2010l, and apolipoprotein B were measured by standard methods in a group of Type 2 diabetic patients affected by persistent microalbuminuria (albumin excretion rate (AER) 20\u2013200 \u03bcg min<jats:sup>\u22121<\/jats:sup>) as compared with a group of sex\u2010 and age\u2010matched non\u2010microalbuminuric patients (AER &lt; 20 \u03bcg min<jats:sup>\u22121<\/jats:sup>). The groups were stratified according to a short (&lt; 5 years) or a longer (&gt; 5 years) duration of diagnosed diabetes. Microalbuminuria was not associated with significant changes of serum total\u2010cholesterol, triglycerides, HDL\u2010cholesterol, LDL\u2010cholesterol, and apolipoproteins in the group of patients with a duration of disease &gt; 5 years, while microalbuminuric patients &gt; 5 years from diagnosis (n = 11) had serum total\u2010cholesterol, triglycerides, LDL\u2010cholesterol, and apoprotein B higher than non\u2010microalbuminuric control patients (n = 26) (cholesterol 6.2 \u00b1 0.9 vs 5.1 \u00b11.0 mmol I<jats:sup>\u22121<\/jats:sup> (p = 0.003); triglycerides 2.1 \u00b1 0.7 vs 1.7 \u00b1 1.3 mmol I<jats:sup>\u22121<\/jats:sup> (p = 0.03); LDL\u2010cholesterol 4.1 \u00b1 0.8 vs 3.0 \u00b1 0.7 mmol I<jats:sup>\u22121<\/jats:sup> (p&lt; .001); apo\u2010B 1.3 \u00b1 0.3 vs 1.1 \u00b1 0.3 g I<jats:sup>\u22121<\/jats:sup> (p = 0.02). In these patients with shorter duration of diabetes many of the serum lipid measures correlated positively with AER.<\/jats:p>","DOI":"10.1111\/j.1464-5491.1990.tb01497.x","type":"journal-article","created":{"date-parts":[[2009,7,30]],"date-time":"2009-07-30T10:29:03Z","timestamp":1248949743000},"page":"810-814","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Serum Lipids and Lipoproteins in Type 2 Diabetic Patients with Persistent Microalbuminuria"],"prefix":"10.1111","volume":"7","author":[{"given":"G.","family":"Seghieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Alviggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Caselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.A.","family":"de Giorgio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Breschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Gironi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Niccolai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.C.","family":"Bartolomei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,7,30]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.4.4.447"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00274218"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.294.6588.1648"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.7.2.151"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6672.487"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1989.tb01134.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00276846"},{"key":"e_1_2_1_9_2","volume-title":"Arterial Hypertension","author":"World Health Organization.","year":"1979"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30717-9"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of concentration of low density lipoprotein cholesterol without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald WT","year":"1972","journal-title":"Clin Chem"},{"key":"e_1_2_1_12_2","volume-title":"SAS\/STAT Guide for Personal Computers","author":"SAS Institute Inc.","year":"1987"},{"key":"e_1_2_1_13_2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF00395552","article-title":"Coronary heart disease and urinary albumin excretion rate in Type 2 (non\u2010insulin\u2010dependent) diabetic patients","volume":"31","author":"Mattock MB","journal-title":"Diabetologia"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00285287"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.294.6588.1651"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.37.11.1499"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1988.tb00958.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.1984.tb01915.x"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198402093100605"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(84)90669-0"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1986.03380200073024"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(82)91513-6"},{"key":"e_1_2_1_23_2","first-page":"598","article-title":"Effects of genetic obesity on renal structure and function in the Zucker rat","volume":"106","author":"Kasiske BL","year":"1985","journal-title":"J Lab Clin Invest"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1988.51"}],"container-title":["Diabetic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-5491.1990.tb01497.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-5491.1990.tb01497.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T23:38:09Z","timestamp":1695771489000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-5491.1990.tb01497.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,11]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1990,11]]}},"alternative-id":["10.1111\/j.1464-5491.1990.tb01497.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-5491.1990.tb01497.x","archive":["Portico"],"relation":{},"ISSN":["0742-3071","1464-5491"],"issn-type":[{"value":"0742-3071","type":"print"},{"value":"1464-5491","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,11]]},"assertion":[{"value":"2009-07-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}